EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The relevance of prothrombotic genetic variants in women who experienced pregnancy loss or embryo implantation failure: A retrospective analysis of 1922 cases

Gustavo Cernera iD, Renato Liguori iD, Dario Bruzzese iD, Giuseppe Castaldo iD, Giuseppe De Placido iD, Alessandro Conforti iD, Felice Amato iD, Carlo Alviggi, Marika Comegna

International Journal of Gynecology & Obstetrics · 2024-04 · 165 (1) · 148-154

DOI: 10.1002/ijgo.15282 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Gynecology & Obstetrics, online erschienen am 19.12.2023. Verfasst von Gustavo Cernera und 8 weiteren Autor:innen. Beteiligte Einrichtung: Dipartimento di Medicina Molecolare e Biotecnologie Mediche, Università di Napoli Federico II, Naples, Italy. Hauptthemen laut MEDLINE: Abortion, Habitual, Thrombophilia. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

The aim of our study was that to assess the allelic and genotype frequencies of nine prothrombotic gene variants in patients with a history of pregnancy loss and recurrent pregnancy loss (RPL). Women who underwent assisted reproductive technology (ART) with ongoing pregnancy and those with recurrent implantation failure (RIF) were also included.

Methods

Nine prothrombotic gene variants were evaluated: factor V Leiden (FVL), factor V, H1299R variant (FVR2), factor II (FII) G20210A, methylene‐tetrahydrofolate reductase (MTHFR) C677T and A1298C, beta‐fibrinogen ‐455G>A, factor XIII (FXIII) V34L, human platelet antigen‐1 (HPA‐1) L33P variants, and plasminogen activator inhibitor‐1 (PAI‐1) 4G/5G. The following study groups were assessed: (1) women who experienced one ( n = 334) or two ( n = 264) episodes of pregnancy loss; (2) 468 women who experienced RPL; (3) 214 women who underwent ART followed by ongoing pregnancies; and (4) 282 women who experienced RIF after ART, that is, three or more consecutive implantation failures following high‐quality embryo transfers to the uterus with an appropriate endometrium. As control group, 430 subjects from the general population were enrolled.

Results

FVL, the ‐455G>A variant of beta‐fibrinogen, and PAI‐1 4G were associated with a higher risk of developing RPL compared with the general population. Furthermore, FVL, FVR2, FII G20210A and MTHFR C677T conferred a significantly higher risk of RIF in women who performed ART compared with the general population. No statistical differences between the general population and other study groups were observed.

Conclusions

Specific prothrombotic genetic variants are more frequently expressed in women with RPL and RIF, supporting their role in the development of polimicrothrombosis and impairing the invasion during embryo implantation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Abortion, HabitualThrombophiliaPregnancyHumansFemalePlasminogen Activator Inhibitor 1Retrospective StudiesFactor VEmbryo ImplantationProthrombinFibrinogen

Stichwörter der Autor:innen

assisted reproductive technologygenetic variantsovarian stimulationpolymorphismrecurrent implantation failurerecurrent pregnancy lossthrombophilia

Substanzen

Plasminogen Activator Inhibitor 1Factor VProthrombinFibrinogen

Autor:innen und Institutionen

  • Dipartimento di Medicina Molecolare e Biotecnologie Mediche, Università di Napoli Federico II, Naples, Italy.
  • CEINGE-Biotecnologie avanzate, Naples, Italy.
  • Dipartimento di Sanità Pubblica, Università di Napoli Federico II, Naples, Italy.
  • Dipartimento di Neuroscienze e Scienze Riproduttive e Odontostomatologiche, Università di Napoli Federico II, Naples, Italy.

ORCID-Profile: Gustavo Cernera, Renato Liguori, Dario Bruzzese, Giuseppe Castaldo, Giuseppe De Placido, Alessandro Conforti, Felice Amato

Zitieren

APA

Cernera, G., Liguori, R., Bruzzese, D., Castaldo, G., De Placido, G., Conforti, A., Amato, F., Alviggi, C., & Comegna, M. (2024). The relevance of prothrombotic genetic variants in women who experienced pregnancy loss or embryo implantation failure: A retrospective analysis of 1922 cases. International Journal of Gynecology & Obstetrics, 165(1), 148-154. https://doi.org/10.1002/ijgo.15282

Vancouver

Cernera G, Liguori R, Bruzzese D, Castaldo G, De Placido G, Conforti A, et al. The relevance of prothrombotic genetic variants in women who experienced pregnancy loss or embryo implantation failure: A retrospective analysis of 1922 cases. International Journal of Gynecology & Obstetrics. 2024;165(1):148-154. doi:10.1002/ijgo.15282

BibTeX
@article{Cernera2024,
  author = {Cernera, Gustavo and Liguori, Renato and Bruzzese, Dario and Castaldo, Giuseppe and De Placido, Giuseppe and Conforti, Alessandro and Amato, Felice and Alviggi, Carlo and Comegna, Marika},
  title = {The relevance of prothrombotic genetic variants in women who experienced pregnancy loss or embryo implantation failure: A retrospective analysis of 1922 cases},
  journal = {International Journal of Gynecology & Obstetrics},
  year = {2024},
  volume = {165},
  number = {1},
  pages = {148--154},
  doi = {10.1002/ijgo.15282}
}
Kostenlos starten →